Literature DB >> 17334835

Role of sustained overexpression of central nervous system IGF-I in the age-dependent decline of mouse excitation-contraction coupling.

Ramón Jiménez Moreno1, María Laura Messi, Zhenlin Zheng, Zhong-Min Wang, Ping Ye, Joseph A D'Ercole, Osvaldo Delbono.   

Abstract

We investigated the effects of exclusive and sustained transgenic overexpression of insulin-like growth factor (IGF)-I in the central nervous system (CNS) on the age-dependent decline in muscle strength, excitation-contraction coupling, muscle innervation and neuromuscular junction postterminal architecture. We found that (1) transgenic IGF-I overexpression in the CNS does not modify the decline in extensor digitorum longus (EDL) and soleus muscle weight with aging and (2) strength significantly decreases in transgenic (Tg) compared to wild-type mice. The latter finding is consistent with (3) the decreased absolute and specific force measured in the EDL muscle in vitro and (4) the decreased charge movement and peak intracellular Ca(2+) mobilization in individual muscle fibers from old IGF-I Tg mice compared to young wild-type mice, which also is associated with (5) decreased dihydropyridine receptor alpha(1)-subunit expression in old compared to young IGF-I Tg mice. (6) Tg IGF-I prevents a change in muscle fiber type that is associated with (7) improved muscle innervation and postterminal neuromuscular structure. (8) IGF-I is expressed extensively across the spinal cord gray matter and the lateral motor column. Our results raise questions about the timing and cell location of CNS IGF-I overexpression necessary to prevent or to ameliorate age-dependent alterations in the structure and function of skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17334835     DOI: 10.1007/s00232-006-0044-z

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  62 in total

1.  Differentiation of fast and slow muscles in the cat hind limb.

Authors:  A J BULLER; J C ECCLES; R M ECCLES
Journal:  J Physiol       Date:  1960-02       Impact factor: 5.182

Review 2.  Effects of ageing on the motor unit.

Authors:  L Larsson; T Ansved
Journal:  Prog Neurobiol       Date:  1995-04       Impact factor: 11.685

3.  The effect of ageing and exercise on skeletal muscle function.

Authors:  R H Fitts; J P Troup; F A Witzmann; J O Holloszy
Journal:  Mech Ageing Dev       Date:  1984-10-15       Impact factor: 5.432

4.  Behavioral abnormalities of Zic1 and Zic2 mutant mice: implications as models for human neurological disorders.

Authors:  H Ogura; J Aruga; K Mikoshiba
Journal:  Behav Genet       Date:  2001-05       Impact factor: 2.805

5.  The specific force of single intact extensor digitorum longus and soleus mouse muscle fibers declines with aging.

Authors:  E González; M L Messi; O Delbono
Journal:  J Membr Biol       Date:  2000-12-01       Impact factor: 1.843

Review 6.  Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging.

Authors:  William E Sonntag; Melinda Ramsey; Christy S Carter
Journal:  Ageing Res Rev       Date:  2005-05       Impact factor: 10.895

7.  Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse.

Authors:  L Li; R W Oppenheim; M Lei; L J Houenou
Journal:  J Neurobiol       Date:  1994-07

8.  Creation of an autocrine model of insulin-like growth factor-I action in transfected FRTL-5 cells.

Authors:  Z Dai; S I Takahashi; J J Van Wyk; A J D'Ercole
Journal:  Endocrinology       Date:  1992-06       Impact factor: 4.736

9.  Expression of liver insulin-like growth factor 1 gene and its serum level in patients with diabetes.

Authors:  Jian-Bo Li; Cheng-Ya Wang; Jia-Wei Chen; Zhen-Qing Feng; Hong-Tai Ma
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

10.  Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice.

Authors:  M E Coleman; F DeMayo; K C Yin; H M Lee; R Geske; C Montgomery; R J Schwartz
Journal:  J Biol Chem       Date:  1995-05-19       Impact factor: 5.157

View more
  7 in total

Review 1.  Altered Ca2+ sparks in aging skeletal and cardiac muscle.

Authors:  Noah Weisleder; Jianjie Ma
Journal:  Ageing Res Rev       Date:  2008-01-05       Impact factor: 10.895

2.  Increased CaVbeta1A expression with aging contributes to skeletal muscle weakness.

Authors:  Jackson R Taylor; Zhenlin Zheng; Zhong-Min Wang; Anthony M Payne; María L Messi; Osvaldo Delbono
Journal:  Aging Cell       Date:  2009-08-05       Impact factor: 9.304

3.  Central IGF-1 protects against features of cognitive and sensorimotor decline with aging in male mice.

Authors:  Gabriela E Farias Quipildor; Kai Mao; Zunju Hu; Ardijana Novaj; Min-Hui Cui; Maria Gulinello; Craig A Branch; Sriram Gubbi; Khushbu Patel; Douglas R Moellering; Stefano Tarantini; Tamas Kiss; Andriy Yabluchanskiy; Zoltan Ungvari; William E Sonntag; Derek M Huffman
Journal:  Geroscience       Date:  2019-05-10       Impact factor: 7.713

Review 4.  What is dynapenia?

Authors:  Brian C Clark; Todd M Manini
Journal:  Nutrition       Date:  2012-05       Impact factor: 4.008

5.  The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS.

Authors:  Maria Laura Messi; Heather M Clark; David M Prevette; Ronald W Oppenheim; Osvaldo Delbono
Journal:  Exp Neurol       Date:  2007-06-02       Impact factor: 5.330

6.  Evolving concepts on the age-related changes in "muscle quality".

Authors:  David W Russ; Kimberly Gregg-Cornell; Matthew J Conaway; Brian C Clark
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-02-03       Impact factor: 12.910

Review 7.  Skeletal muscle performance and ageing.

Authors:  Michael Tieland; Inez Trouwborst; Brian C Clark
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-11-19       Impact factor: 12.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.